Efficacy and safety of dapagliflozin in patients with type 2 diabetes and moderate renal impairment (CKD Stage 3A): The DERIVE Study - Fioretto, P; Del Prato, S; Buse, J B (Diabetes Obes Metab, 2018)
et al.